Ticker Details
Evofem Biosciences, Inc. Evofem Biosciences Inc provides woman-controlled protection from sexually transmitted infections. It addresses women's unmet medical needs through the discovery, development and commercialization of healthcare products.
IPO Date:	November 20, 2014
Sector:	Healthcare
Industry:	Biotech
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.12 | 4.97%
Avg Daily Range (30 D):	$0.00 | 0.00%
Avg Daily Range (90 D):	$0.01 | 37.50%

Institutional Daily Volume
Avg Daily Volume:	2.61M
Avg Daily Volume (30 D):	.4M
Avg Daily Volume (90 D):	.53M

Trade Size
Avg Trade Size (Sh.):	652
Avg Trade Size (Sh.) (30 D):	20,177
Avg Trade Size (Sh.) (90 D):	18,049

Institutional Trades
Total Institutional Trades:	61
Avg Institutional Trade:	$1.93M
Avg Institutional Trade (30 D):	$.5M
Avg Institutional Trade (90 D):	$.74M
Avg Institutional Trade Volume:	M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.6M
Avg Closing Trade (30 D):	$M
Avg Closing Trade (90 D):	$M
Avg Closing Volume:	1.01K

News

Nov 21, 2025 @ 2:25 PM Favorable Pricing Certificates Issued for Evofem's... Source: Prnewswire

Nov 13, 2025 @ 9:05 PM Evofem Reports Financial Results for Third Quarter... Source: Prnewswire

Oct 20, 2025 @ 8:19 PM Evofem Announces Voting Results from Special Meeti... Source: Prnewswire

Oct 1, 2025 @ 12:47 PM Evofem's SOLOSEC Submitted for Marketing Approval ... Source: Prnewswire

Sep 26, 2025 @ 12:15 PM Evofem Biosciences Honors World Contraception Day Source: Prnewswire

Financials
	TTM	Q2 2022	Q1 2022
Basic EPS	$.31	$-4.57	$-2.88
Diluted EPS	$.31	$-4.57	$-2.88
Revenue	$.18M	$6.03M	$4.25M
Gross Profit	$-.2M	$4.75M	$3.19M
Net Income / Loss	$-8.34M	$-125.98M	$-31.89M
Operating Income / Loss	$-12.05M	$-24.42M	$-28.93M
Cost of Revenue	$.38M	$1.29M	$1.07M
Net Cash Flow	$-5.07M	$14.53M	$-5.86M
PE Ratio	0.03

Splits
May 18, 2023	1:125
May 06, 2022	1:15
Jan 18, 2018	1:6